USPTO serial 99528347
NEXMED
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 23, 2026
- Examiner
- STAHL, NICHOLE MARIE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NEXMED?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Holbrook, NY, US
Holbrook, NY, US
Holbrook, NY, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Allergy capsules; Allergy medications; Allergy relief medication; Allergy medication; Analgesic preparations; Analgesic balm; Topical analgesic creams; Effervescent analgesic pharmaceutical preparations; Analgesic and muscle relaxant pharmaceutical preparations; Ibuprofen for use as an oral analgesic; Multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Analgesics; Anti-inflammatories; Anti-inflammatory ointments; Anti-inflammatory salves; Anti-inflammatory gels; Anti-inflammatory preparations; Anti-inflammatory sprays; Homeopathic anti-inflammatory ointment; Anti-inflammatory and antipyretic preparations; Analgesic and anti-inflammatory preparations; Croton bark for use as an anti-inflammatory; Cold sore treatment preparations; Nutritional supplements; Nutritional supplement shakes; Liquid nutritional supplement; Vegan nutritional supplements; Mineral nutritional supplements; Powdered nutritional supplement concentrate; Nutritional supplement energy bars; Dietary supplements; Homeopathic supplements; Probiotic supplements; Mineral supplements; Herbal supplements; Vitamin supplements; Calcium supplements; Food supplements; Prebiotic supplements; Laxative suppositories; Laxatives; Sleeping pills/tablets; Amino acids for nutritional purposes; First aid kits; First aid kits for domestic or other non-professional use; Medicinal roots; Medicinal drinks; Medicinal herbs; Medicinal tea; Medicinal herbal preparations; Antibiotic tablets; Antibiotic preparations; Antibiotic handwash; Antibiotic ointments; Mixed antibiotic preparations; Antibiotic creams; Antibiotic hand wash; Nasal drops for the treatment of allergies; Natural herbal supplements; Natural dietary supplements; Natural supplements for treating candida; Natural supplements for treating erectile dysfunction; Natural supplements for treating depression and anxiety; Natural dietary supplements for treatment of claustrophobia; Topical first aid gel; Topical gel for medical and therapeutic use, namely, ultrasound gel; Non-medicated topical gel for the prevention and treatment of allergies; Non-medicated topical gel for the prevention and treatment of cold and flu; Pharmaceutical preparations, namely, dantrolene sodium for injection; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical products for the prevention and treatment of cancer; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Capsules sold empty for pharmaceuticals; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations, namely, antivirals; Myrobalan bark for pharmaceutical purposes; Pepsins for pharmaceutical purposes; Extracts of hops for pharmaceutical purposes; Rhubarb roots for pharmaceutical purposes; Stick liquorice for pharmaceutical purposes; Flowers of sulfur for pharmaceutical purposes; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of hyperlipidemia; Melissa water for pharmaceutical purposes; Ethers for pharmaceutical purposes; Guaiacol for pharmaceutical purposes; Malt for pharmaceutical purposes; Balms for pharmaceutical purposes; Pharmaceutical preparations for peripheral nervous system; Digestives for pharmaceutical purposes; Pharmaceutical products for treating respiratory diseases; Pharmaceutical preparation for skin care; Pharmaceutical preparations, namely, injectable contraceptives; Anti-diabetic pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Pharmaceutical preparations for treating chemical imbalances; Anti-epileptic pharmaceutical preparations; Turpentine for pharmaceutical purposes; Flaxseed for pharmaceutical purposes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Ferments for pharmaceutical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Cardiovascular pharmaceuticals; Meal for pharmaceutical purposes; Hyaluronic acid for pharmaceutical purposes; Cream of tartar for pharmaceutical purposes; Cellulose ethers for pharmaceutical purposes; Bromine for pharmaceutical purposes; Cellulose esters for pharmaceutical purposes; Bicarbonate of soda for pharmaceutical purposes; Charcoal for pharmaceutical purposes; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Veterinary pharmaceutical compounds for equine use to treat conditions of the leg, hoof, ear, nose and throat; Potassium preparations for pharmaceutical purposes; Pharmaceuticals, namely, psychotropics; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, antihelmintics; Pharmaceutical antitussive-cold preparations; Ocular pharmaceuticals; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for skin care; Mint for pharmaceutical purposes; Antibacterial pharmaceuticals; Pharmaceutical preparations for the treatment of hyperhidrosis; Yeast extracts for pharmaceutical purposes; Gardenia for pharmaceutical purposes; Starch for pharmaceutical purposes; Aluminium acetate for pharmaceutical purposes; Flaxseed meal for pharmaceutical purposes; Pharmaceutical preparations for treating halitosis; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Topical anesthetics; Cough syrups; Cough lozenges; Cough expectorants; Cough drops; Cough suppressants; Cough treatment inhalants; Cough treatment preparations; Cough pastilles for medical use; Cough syrups for medical use | ACTIVE | Dec 1, 2025 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 23, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 23, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 5, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 5, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 29, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 7, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 7, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 3, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 3, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 3, 2025 | NWAP | NEW APPLICATION ENTERED | — |